PERSPECTIVE THERAPEUTICS, INC.

2401 Elliott Avenue, Suite 320

Seattle, Washington 98121

December 13, 2023

VIA EDGAR

Office of Industrial Applications and Services

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attn: Benjamin Richie

  Margaret Schwartz

Re: Perspective Therapeutics, Inc.

Registration Statement on Form S-3, as amended

Filed November 17, 2023
Amended December 7, 2023

File No. 333-275638

Request for Acceleration of Effective Date

To Whom it May Concern,

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Perspective Therapeutics, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on December 14, 2023, or as soon thereafter as possible.

Please direct any questions or comments concerning this request to Stephen M. Nicolai of Hogan Lovells US LLP at (267) 675-4642. Also, please notify Mr. Nicolai when this request for acceleration has been granted.

Very truly yours,

PERSPECTIVE THERAPEUTICS, INC.

By: /s/ Johan (Thijs) Spoor                           

Name:    Johan (Thijs) Spoor

Title:      Chief Executive Officer